Available Until 4/2/2025
View Cart

When Low is the Way to Go: The Skinny on Low-dose Buprenorphine Inductions

ACPE Activity Number: 0204-0000-23-033-H01-P
Release Date: 04/01/2023
Expiration Date: 04/02/2025
Activity Type: Knowledge-based
CE Credits:  0.25 contact hour, no partial credit
Activity Fee: Member – Free / Non-Member – Not Available 

Activity Overview 

The practice of starting buprenorphine is evolving in the era of illicit fentanyl. Pharmacists need to know why and how to successfully start low doses of buprenorphine in patients with OUD to improve access to this life-saving treatment for OUD. 

ACPE Provider with Commendation logo

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

These activities were planned to meet the educational needs of pharmacists who may provide care for patients with Opioid Use Disorder (OUD). 

After completing this activity, the learner should be able to… 

  • Discuss the indications and dosing regimens for low-dose buprenorphine induction.
  • Describe potential pitfalls and clinical monitoring of low dose buprenorphine inductions. 

  • Introduction and Announcements 

  • Presentation  

Stephanie Abel, PharmD, BCPS
Opioid Stewardship Program Coordinator
University of Kentucky HealthCare
Lexington, KY

Maria Foy PharmD, BCPS, CPE
Advanced Clinical Pharmacist Specialist
Jefferson Abington Health 

Tanya J. Uritsky, PharmD
Opioid Stewardship Coordinator
Hospital of the University of Pennsylvania
Philadelphia, PA

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.